APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:APR Applied Pharma Research SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3039
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfolio includes nexodyn, gemiax, exelya, APR 1301-01, APR 1203-01 and APR 1204. The company offers services such as oral formulations, tropical formulations and analytical services. It develops products for various therapeutic areas including cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
APR Applied Pharma Research Raises Funds through Venture Financing 11
Private Equity 12
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
Partnerships 13
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Licensing Agreements 15
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA – Key Competitors 21
APR Applied Pharma Research SA – Key Employees 22
APR Applied Pharma Research SA – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Product News 24
Sep 05, 2017: PKU: Pre-Clinical Kinetic Data Showing Prolonged Release of Amino Acids Thanks to the Innovative Physiomimic Technology by APR Presented at the 13th ICIEM Congress (September 5th-8th, Rio de Janeiro) 24
Apr 06, 2017: APR Applied Pharma Research Wants to Make the Difference for PKU People Thanks to an Innovative and Patented Technology 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Key Facts 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research Raises Funds through Venture Financing 11
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA, Key Competitors 21
APR Applied Pharma Research SA, Key Employees 22

List of Figures
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMETEK Inc (AME):企業の財務・戦略的SWOT分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturer. The company manufactures electronic instruments and electromechanical devices. Its product portfolio includes medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys a …
  • Benitec Biopharma Ltd (BLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based th …
  • Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Al Ain Ahlia Insurance Company PSC:企業の戦略・SWOT・財務分析
    Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report Summary Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Fresenius Medical Care AG & Co KGaA (FMS):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Argan Inc (AGX):企業の財務・戦略的SWOT分析
    Argan Inc (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Clark Construction Group, LLC:企業の戦略的SWOT分析
    Clark Construction Group, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Technical Olympic SA:企業の戦略・SWOT・財務情報
    Technical Olympic SA - Strategy, SWOT and Corporate Finance Report Summary Technical Olympic SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bancolombia S.A.:企業の戦略・SWOT・財務分析
    Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report Summary Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Emirates Telecommunications Group Company PJSC:企業のM&A・事業提携・投資動向
    Emirates Telecommunications Group Company PJSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Emirates Telecommunications Group Company PJSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • eResearchTechnology Inc:企業の戦略的SWOT分析
    eResearchTechnology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Societe Generale S.A.:戦略・SWOT・企業財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Co-Diagnostics Inc (CODX):企業の製品パイプライン分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Akari Therapeutics Plc (AKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a …
  • Enzo Biochem Inc (ENZ):企業の財務・戦略的SWOT分析
    Enzo Biochem Inc (ENZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Modiin Energy Limited Partnership (MDIN.L):石油・ガス:M&Aディール及び事業提携情報
    Summary Modiin Energy Limited Partnership (Modiin Energy) is an oil and gas company that offers crude oil exploration programs. The company operates in the exploration and development of oil and natural gas properties. It owns and operates five assets such as Shimshon, Daniel east, Daniel west, Grap …
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆